drugset / Trial / NCT00105482
Targeted Interventions for Weight-Concerned Smokers
Phase 2
Completed
172 enrolled
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Weight gain after quitting smoking is an important barrier to treatment for many smokers. This study will test a drug called naltrexone with weight-concerned smokers to investigate whether or not this drug both improves smoking cessation quit rates and minimizes post quit weight gain.
Timeline
- Start
- 2005-01
- Primary completion
- 2009-04
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 25 mg | Oral |
| Background | Nicotine | Unknown | 21 mg | Other |